uniQure N.V. (QURE) financial statements (2022 and earlier)

Company profile

Business Address PAASHEUVELWEG 25A
AMSTERDAM, 1105 BP
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments556245378235159132
Cash and cash equivalents556245378235159132
Receivables 71029
Prepaid expense1145111
Other current assets 31011
Other undisclosed current assets61     
Total current assets:628259384237163144
Noncurrent Assets
Operating lease, right-of-use asset262627
Property, plant and equipment443229293436
Intangible assets, net (including goodwill)90466109
Goodwill2810110
Intangible assets, net (excluding goodwill)63355108
Deferred income tax assets1616 
Other noncurrent assets6   22
Other undisclosed noncurrent assets 332  
Total noncurrent assets:1818164374746
TOTAL ASSETS:809340449274210190
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3122189910
Accounts payable346436
Accrued liabilities281812   
Employee-related liabilities   664
Deferred revenue  8
Debt  6 11
Deferred rent credit   0
Business combination, contingent consideration, liability    1 
Deferred revenue and credits57
Contract with customer, liability8
Other liabilities   110
Other undisclosed current liabilities66 225
Total current liabilities:372732201923
Noncurrent Liabilities
Long-term debt and lease obligation1306667352020
Long-term debt, excluding current maturities1013636352020
Operating lease, liability293031
Liabilities, other than long-term debt47327398184
Deferred revenue and credits7782
Deferred revenue  23
Contract with customer, liability29
Deferred rent credit   9
Deferred income tax liabilities13  
Other liabilities431010
Business combination, contingent consideration, liability30   32
Derivative instruments and hedges, liabilities  311 
Total noncurrent liabilities:177699474101104
Total liabilities:2139612694120127
Stockholders' equity
Stockholders' equity attributable to parent5962443231808964
Common stock333222
Additional paid in capital1,0771,016987720567465
Accumulated other comprehensive income (loss)(29)10(7)(7)(4)(7)
Accumulated deficit(455)(785)(660)(536)(475)(396)
Total stockholders' equity:5962443231808964
TOTAL LIABILITIES AND EQUITY:809340449274210190

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues524387111325
Revenue, net41
Other income1232   
Cost of revenue(169)(122)(95)(1)(1)(1)
Cost of goods and services sold(25)(3)(2)(1)(1)(1)
Gross profit:355(85)(87)101224
Operating expenses(56)(43)(34)(100)(97)(99)
Other operating expense, net
(Other Expenses)
(1)(1)(2)   
Other undisclosed operating income12322133
Operating income (loss):311(125)(121)(88)(71)(72)
Nonoperating income (expense)30(12)17(6)2
Investment income, nonoperating014300
Foreign currency transaction gain (loss), before tax30(14)(0)4(4)1
Other nonoperating income (expense)(0)0(3)0(2)1
Interest and debt expense(7)(4)(4)(2)(2)(2)
Income (loss) from continuing operations before income taxes:333(141)(124)(83)(79)(72)
Income tax expense (benefit)(3)16 (0)0(1)
Net income (loss) available to common stockholders, diluted:330(125)(124)(83)(79)(73)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):330(125)(124)(83)(79)(73)
Comprehensive income (loss):330(125)(124)(83)(79)(73)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(39)171(5)30
Comprehensive income (loss), net of tax, attributable to parent:291(108)(124)(89)(77)(73)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: